title: Except for alanine, muscle protein catabolism is not influenced by alterations in glucose metabolism during sepsis.
abstract: OBJECTIVE
  To assess any relationship between hyperglycemia and muscle protein catabolism associated with critical illness.
  
  
  METHODS
  Cohort analytic study.
  
  
  METHODS
  Clinical research center and intensive care unit of a university hospital.
  
  
  METHODS
  Six healthy volunteers and five patients with severe sepsis.
  
  
  METHODS
  Study subjects were given infusions of 6,6,d2 glucose and 15N lysine for 6 hours. After infusion of the stable isotopes for 2 hours (basal period), dichloroacetate, which accelerates pyruvate oxidation, was given (dichloroacetate period). Leg blood flow was measured by indocyanine green dye dilution, and femoral artery and vein substrate concentrations were quantitated.
  
  
  METHODS
  The metabolic rates of glucose production, oxidation, and clearance; the whole-body protein breakdown rate; and the net efflux of amino acids from the leg were determined.
  
  
  RESULTS
  In comparison with the healthy volunteers, septic patients had significant elevations in glucose production, oxidation, and clearance, accelerated protein catabolism, and greater net peripheral efflux of amino acids. Dichloroacetate significantly decreased glucose production and increased the percentage of glucose directed toward oxidation in both healthy volunteers and septic patients. However, this dichloroacetate-induced perturbation of glucose utilization had no significant effect on whole-body protein breakdown or the efflux of specific amino acids from the leg except for alanine, whose net efflux doubled (P < or = .05).
  
  
  CONCLUSIONS
  The findings of this study demonstrate a universal acceleration in the metabolic rates of both intermediary glucose metabolism and protein/amino acid catabolism during sepsis. Except for alanine, however, there appears to be no coupling between these two physiologic responses to sepsis.
mesh_terms: D000328:Adult; D000368:Aged; D000409:Alanine / Q000378:metabolism*; D016022:Case-Control Studies; D015331:Cohort Studies; D005260:Female; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009124:Muscle Proteins / Q000378:metabolism*; D018805:Sepsis / Q000150:complications / Q000378:metabolism*
chemical_list: D009124:Muscle Proteins; D005947:Glucose; D000409:Alanine